Quality of life in the early assessment of benefit in Germany: a qualitative study

被引:0
|
作者
Blome, Christine [1 ]
Lohrberg, David [2 ]
Augustin, Matthias [2 ]
机构
[1] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany
[2] Univ Med Ctr Hamburg, Hamburg, Germany
关键词
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
103.1
引用
收藏
页码:17 / 18
页数:2
相关论文
共 50 条
  • [31] Longitudinal Quality of Life Assessment in Liver Transplant Feasibility Study and Early Results
    Siddiqui, O. M.
    Polineni, P.
    Thuluvath, A. J.
    Loftus, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 757 - 758
  • [33] How animals communicate quality of life: the qualitative assessment of behaviour
    Wemelsfelder, F.
    ANIMAL WELFARE, 2007, 16 : 25 - 31
  • [34] Nasal valve surgery: Assessment of quality of life with the Glasgow Benefit Inventory
    Manickavasagam, Jaiganesh
    Wong, Smeeta
    Varabei, Veronika
    Raghavan, Ullas
    ENT-EAR NOSE & THROAT JOURNAL, 2014, 93 (4-5) : 174 - +
  • [35] Quality of life measurement: a suitable method for benefit-risk assessment?
    Kohlmann, Thomas
    ZEITSCHRIFT FUR EVIDENZ FORTBILDUNG UND QUALITAET IM GESUNDHEITSWESEN, 2011, 105 (03): : 157 - 162
  • [36] Methodology for analysing quality-of-life data in the benefit assessment of pharmaceuticals
    Leverkus, Friedhelm
    ZEITSCHRIFT FUR EVIDENZ FORTBILDUNG UND QUALITAET IM GESUNDHEITSWESEN, 2014, 108 (2-3): : 111 - 119
  • [37] The clinical value of quality of life assessment in oncology practice - a qualitative study of patient and physician views
    Velikova, Galina
    Awad, Noha
    Coles-Gale, Rebecca
    Wright, E. Penny
    Brown, Julia M.
    Selby, Peter J.
    PSYCHO-ONCOLOGY, 2008, 17 (07) : 690 - 698
  • [38] Effect of Crossover in Oncology Clinical Trials on Evidence Levels in Early Benefit Assessment in Germany
    Isbary, Georg
    Staab, Thomas R.
    Amelung, Volker E.
    Dintsios, Charalabos-Markos
    Iking-Konert, Christof
    Nesurini, Sonja Mariotti
    Walter, Miriam
    Ruof, Jorg
    VALUE IN HEALTH, 2018, 21 (06) : 698 - 706
  • [39] IMPACT OF TRIAL DESIGN ON PRICE DISCOUNTS AFTER EARLY BENEFIT ASSESSMENT (AMNOG) IN GERMANY
    Theidel, U.
    Lopmeier, J.
    Mittendorf, T.
    VALUE IN HEALTH, 2016, 19 (07) : A501 - A501
  • [40] AMNOG - SUMMARY OF OUTCOMES OF EARLY BENEFIT ASSESSMENT AND REIMBURSEMENT NEGOTIATION FOR NEW DRUGS IN GERMANY
    Claus, V
    Freyer, D.
    Kotowa, W.
    Mathes, J.
    VALUE IN HEALTH, 2012, 15 (07) : A316 - A316